<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/20/maximus-nysemms-releases-quarterly-earnings-results-misses-estimates-by-0-01-eps.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-20T10:16:45+00:00"/>
    <meta property="og:title" content="MAXIMUS (NYSE:MMS) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS"/>
    <meta property="og:description" content="MAXIMUS (NYSE:MMS) posted its quarterly earnings results on Tuesday. The health services provider reported $0.93 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.01), Briefing.com reports. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The company had revenue of $754.97 million for the quarter, compared to […]"/>
  </head>
  <body>
    <article>
      <h1>MAXIMUS (NYSE:MMS) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS</h1>
      <address><time datetime="2019-11-20T10:16:45+00:00">20 Nov 2019, 10:16</time> by <a rel="author" href="https://www.thecerbatgem.com/author/doug" target="_blank">Doug Wharley</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/maximus-logo.jpg"/>
      </figure>
      <p>MAXIMUS (NYSE:MMS) posted its quarterly earnings results on Tuesday. The health services provider reported $0.93 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.01), <a href="https://www.briefing.com/">Briefing.com</a> reports. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The company had revenue of $754.97 million for the quarter, compared to analysts’ expectations of $756.40 million. During the same quarter in the prior year, the firm earned $0.71 EPS. The firm’s revenue was up 35.2% on a year-over-year basis. MAXIMUS updated its FY20 guidance to $3.95-4.15 EPS.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NYSE/MMS/earnings/">NYSE:MMS</a> traded down $0.40 during midday trading on Wednesday, reaching $75.82. 39,548 shares of the company’s stock were exchanged, compared to its average volume of 407,988. The firm’s 50 day simple moving average is $75.85 and its two-hundred day simple moving average is $75.06. The stock has a market cap of $4.95 billion, a price-to-earnings ratio of 22.30, a P/E/G ratio of 1.90 and a beta of 0.82. MAXIMUS has a fifty-two week low of $60.00 and a fifty-two week high of $82.02.</p>
      <p>The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.48%. This is an increase from MAXIMUS’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Thursday, November 14th. MAXIMUS’s dividend payout ratio (DPR) is presently 32.94%.</p>
      <p>In related news, Vice Chairman Richard A. Montoni sold 11,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $80.40, for a total transaction of $884,400.00. Following the completion of the sale, the insider now directly owns 337,874 shares of the company’s stock, valued at approximately $27,165,069.60. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through <a href="https://www.sec.gov/Archives/edgar/data/1032220/000103222019000085/xslF345X03/primary_doc.xml">the SEC website</a>. Also, Director Russell A. Beliveau sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $77.46, for a total value of $77,460.00. The disclosure for this sale can be found <a href="https://www.sec.gov/Archives/edgar/data/1032220/000103222019000092/xslF345X03/primary_doc.xml">here</a>. Insiders have sold a total of 55,496 shares of company stock valued at $4,398,575 over the last three months. Corporate insiders own 2.20% of the company’s stock.</p>
      <p>Several research analysts have recently commented on MMS shares. Wells Fargo &amp; Co reiterated a “market perform” rating and set a $83.00 price target on shares of MAXIMUS in a report on Friday, August 9th. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=MMS">ValuEngine</a> upgraded MAXIMUS from a “sell” rating to a “hold” rating in a report on Friday, October 25th. Finally, Canaccord Genuity lifted their price target on MAXIMUS from $72.00 to $77.00 and gave the stock a “hold” rating in a report on Tuesday, August 13th.</p>
      <p>
        <b>MAXIMUS Company Profile</b>
      </p>
      <p>MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.</p>
      <p>Further Reading: <a href="https://www.marketbeat.com/financial-terms/what-is-depreciation/">Depreciation</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=MMS"/>
      </figure>
    </article>
  </body>
</html>